Suspension of trading
Quotes Cerevel Therapeutics Holdings, Inc.
Stocks
CERE
US15678U1280
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2024-07-31 EDT
|
5-day change | 1st Jan Change | ||
| 44.96 USD | +0.74% |
|
-.--% | - |
Stock exchange
Nasdaq
CERE 44.96 $
+0.74%
679M
$
| Markets | Price | Change | Volumes |
|---|
Performance
| 1 day | +0.74% | ||
| 3 years | +86.48% | ||
| 5 years | +27.76% |
Volumes
marketsCapital turnover ratio
0
Float rotation
0
Basic data
Market Cap (USD)
8,191,474,701
Net sales ()
-
Number of employees
355
Sales / Employee ()
0
Sales / Employee (USD)
0
Free-Float
93.64 %
Free-Float capitalization (USD)
7,670,416,311
Indicators
Moving average 5 days
44.66
Moving average 100 days
41.9
Price spread / (MMA5)
-0.68%
Price spread / (MMA100)
-6.81%
STIM
RSI 9 days
0
RSI 14 days
0
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.74% | -.--% | -.--% | +86.48% | 8.19B | ||
| -1.79% | -2.27% | +43.23% | +88.96% | 67.98B | ||
| -2.06% | -0.18% | +39.67% | +86.44% | 64.94B | ||
| -0.31% | +6.54% | -12.96% | +378.92% | 27.58B | ||
| +0.86% | +1.65% | -7.74% | -14.95% | 26.06B | ||
| -3.00% | -2.90% | +33.13% | +12.54% | 25.74B | ||
| -1.46% | +0.42% | +23.61% | -18.61% | 20.09B | ||
| -2.96% | -15.21% | +216.20% | +368.10% | 17.16B | ||
| -1.49% | -4.88% | -6.60% | +531.89% | 14.92B | ||
| -0.20% | +8.37% | +55.78% | +164.98% | 14.62B | ||
| Average | -1.17% | +0.23% | +38.43% | +168.47% | 28.73B | |
| Weighted average by Cap. | -1.46% | +0.17% | +37.28% | +135.90% |
Historical Quotes: Cerevel Therapeutics Holdings, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
| 3 years | 19.59 | 44.99 | |
| 5 years | 19.59 | 46.16 | |
| 10 years | 9 | 46.16 |
Monthly variations
Annual variations
| 2024 | +6.04% | ||
| 2023 | +34.43% | ||
| 2022 | -2.71% | ||
| 2021 | +95.54% | ||
| 2020 | +39.33% |
- Stock Market
- Stocks
- CERE Stock
- Quotes Cerevel Therapeutics Holdings, Inc.
Select your edition
All financial news and data tailored to specific country editions
















